Growth Metrics

Standard Biotools (LAB) Other Non-Current Liabilities (2016 - 2025)

Standard Biotools (LAB) has disclosed Other Non-Current Liabilities for 16 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities rose 14.41% to $1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Dec 2025, up 14.41% year-over-year, with the annual reading at $1.2 million for FY2025, 14.41% up from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $1.2 million at Standard Biotools, up from $1.2 million in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $3.5 million in Q1 2025, with the low at $276000.0 in Q2 2021.
  • Average Other Non-Current Liabilities over 5 years is $1.3 million, with a median of $1.2 million recorded in 2022.
  • The sharpest move saw Other Non-Current Liabilities tumbled 63.19% in 2023, then soared 412.73% in 2024.
  • Over 5 years, Other Non-Current Liabilities stood at $882000.0 in 2021, then grew by 8.96% to $961000.0 in 2022, then increased by 10.82% to $1.1 million in 2023, then dropped by 0.28% to $1.1 million in 2024, then increased by 14.41% to $1.2 million in 2025.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $1.2 million, $1.2 million, and $1.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.